Citizens Reiterates Dynavax Technologies (DVAX) at Market Outperform Post Phase 1/2 Results
Tweet Send to a Friend
Citizens analyst Roy Buchanan reiterated a Market Outperform rating and $32.00 price target on Dynavax Technologies (NASDAQ: DVAX).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
